# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001093557-19-000103
Filing Date
2019-04-19
Accepted
2019-04-19 14:47:17
Documents
8
Period of Report
2019-05-30
Effectiveness Date
2019-04-19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | dxcm-2019xdef14a.htm | DEF 14A | 1200241
2 |  | dexcomlogo1.jpg | GRAPHIC | 83644
3 |  | ceosignature.jpg | GRAPHIC | 29726
4 |  | dxcmtsr2018.jpg | GRAPHIC | 17993
5 |  | dxcm5yearceocomp2018.jpg | GRAPHIC | 56130
6 |  | dxcmcompelements2018v4.jpg | GRAPHIC | 26829
7 |  | dxcmproxycard12019.jpg | GRAPHIC | 245406
8 |  | dxcmproxycard22019.jpg | GRAPHIC | 178872
| Complete submission text file | 0001093557-19-000103.txt |  | 2081278

Mailing Address 6340 SEQUENCE DRIVE SAN DIEGO CA 92121
Business Address 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 8582000200
DEXCOM INC (Filer) CIK: 0001093557 (see all company filings)

EIN.: 330857544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51222 | Film No.: 19757735
SIC: 3841 Surgical & Medical Instruments & Apparatus